Report

Artificial intelligence in managed care: Trends from 2024 to 2026

Artificial intelligence is moving from early experimentation to more practical application across managed care. In this report, Cencora examines how payer perspectives and adoption patterns evolved from 2024 through 2026, highlighting where artificial intelligence is gaining traction, where organizations are seeing measurable value, and which barriers continue to slow broader scale.

Drawing on three years of survey data from healthcare decision-makers, the report explores how managed care organizations are applying artificial intelligence across administrative, analytical, and clinically adjacent workflows. It also examines the growing importance of governance, transparency, system integration, and human oversight as organizations work to adopt artificial intelligence responsibly.

Key highlights

  • AI adoption is progressing from awareness to implementation, with many organizations now scaling beyond pilot programs.
  • Prior authorization is emerging as one of the strongest use cases, particularly in documentation review, clinical decision support, and turnaround time.
  • Administrative operations currently show the broadest measurable value, including improvements in claims processing, reporting, and documentation.
  • AI is expanding into drug utilization review and medication safety, supporting high-risk member identification, drug-drug interaction detection, and alert optimization.
  • Governance remains critical as organizations address data quality, privacy, compliance, explainability, and accountability.
  • Future opportunities are expected to center on more predictive, proactive, and connected workflows across managed care.
doctor-ai-in-managed-care-trends-report-vea

Download the white paper

We're here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
abstract

Related resources

Article

CMC reality check: Late-stage risks that impact approval

White paper

Resilience as a competitive advantage
Learn more about 3PL partnerships in the pharma and biopharma landscape

White paper

Achieving success in a changing pharmaceutical landscape